Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is to evaluate the effectiveness of nsPFA in treating papillary thyroid microcarcinoma. T
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Dobrowolna, pisemna zgoda na uczestnictwo w badaniu
- •Gotowość uczestniczyć we wszystkich wizytach kontrolnych
- •Rak tarczycy o rozmiarze do 1,5 cm bez przerzutów
- •Prawidłowe wyniki morfologii, testów krzepnięcia i hormonów tarczycy
- •U kobiet w wieku rozrodczym: ujemny test ciążowy przed procedurą
- •Zgoda na stosowanie antykoncepcji przez czas trwania badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 10, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (2)
Sarasota Memorial Hospital
Sarasota, United States
The University of Texas M. D. Anderson Cancer Center
Houston, United States
Trial contact
Victoria E Banuchi, MPH
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.